[go: up one dir, main page]

PE20211248A1 - Formulacion que comprende material nanoestructurado, biocompatible y biocatalitico para el tratamiento de heridas e infecciones - Google Patents

Formulacion que comprende material nanoestructurado, biocompatible y biocatalitico para el tratamiento de heridas e infecciones

Info

Publication number
PE20211248A1
PE20211248A1 PE2020000091A PE2020000091A PE20211248A1 PE 20211248 A1 PE20211248 A1 PE 20211248A1 PE 2020000091 A PE2020000091 A PE 2020000091A PE 2020000091 A PE2020000091 A PE 2020000091A PE 20211248 A1 PE20211248 A1 PE 20211248A1
Authority
PE
Peru
Prior art keywords
formulation
wounds
biocompatible
infections
treatment
Prior art date
Application number
PE2020000091A
Other languages
English (en)
Inventor
Tessy Maria Lopez-Goerne
Original Assignee
Gomez Lopez Wenceslao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gomez Lopez Wenceslao filed Critical Gomez Lopez Wenceslao
Publication of PE20211248A1 publication Critical patent/PE20211248A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Referido a una formulacion que comprende material nanoestructurado, biocompatible y biocatalitico que comprende un acido solido hecho de oxidos mixtos de silice y titania (TiO2-SiO2); soporte en su matriz dispersa: cobre, plata, oro, hierro, rutenio, rodio, paladio, zinc, manganeso, iridio y/o platino en concentraciones minimas, para su uso en el tratamiento de heridas e infecciones. En donde la formulacion esta en forma de gel o liquido.
PE2020000091A 2017-07-20 2018-07-18 Formulacion que comprende material nanoestructurado, biocompatible y biocatalitico para el tratamiento de heridas e infecciones PE20211248A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762534747P 2017-07-20 2017-07-20
PCT/IB2018/055336 WO2019016724A2 (en) 2017-07-20 2018-07-18 FORMULATION COMPRISING NANOSTRUCTURED, BIOCOMPATIBLE AND BIOCATALYTIC MATERIAL FOR THE TREATMENT OF WOUNDS AND INFECTIONS

Publications (1)

Publication Number Publication Date
PE20211248A1 true PE20211248A1 (es) 2021-07-13

Family

ID=65015927

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2020000091A PE20211248A1 (es) 2017-07-20 2018-07-18 Formulacion que comprende material nanoestructurado, biocompatible y biocatalitico para el tratamiento de heridas e infecciones

Country Status (13)

Country Link
US (1) US20200147259A1 (es)
EP (1) EP3654944B1 (es)
JP (1) JP2020528084A (es)
KR (1) KR20200091378A (es)
CN (1) CN111093630A (es)
BR (1) BR112020001041A2 (es)
CA (1) CA3070322A1 (es)
CL (1) CL2020000129A1 (es)
CO (1) CO2020001810A2 (es)
EC (1) ECSP20013310A (es)
PE (1) PE20211248A1 (es)
SG (1) SG11202000506VA (es)
WO (1) WO2019016724A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250111763A (ko) 2024-01-15 2025-07-23 주식회사 바우 상하 이동식 칸막이를 가진 책상

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04231062A (ja) * 1990-09-18 1992-08-19 Create Medic Kk 抗菌性医療用品
US6333093B1 (en) * 1997-03-17 2001-12-25 Westaim Biomedical Corp. Anti-microbial coatings having indicator properties and wound dressings
US6582713B2 (en) * 2000-04-06 2003-06-24 Univ. Of Colorado - Colorado Springs Compositions and methods for promoting wound healing
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
WO2006137851A2 (en) * 2004-09-16 2006-12-28 Virginia Tech Intellectual Properties, Inc. Preparation of stable high concentration colloidal metal particulate systems
US7517536B2 (en) * 2005-11-25 2009-04-14 Feng Chia University Antimicrobial compositions and wound dressings
GB2432529B (en) * 2005-11-25 2008-04-23 Univ Feng Chia Antimicrobial compositions and wound dressings
US7820583B2 (en) * 2006-08-24 2010-10-26 Millennium Inorganic Chemicals, Inc. Nanocomposite particle and process of preparing the same
US8026382B2 (en) * 2007-05-18 2011-09-27 Heidi Kay Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods
DE102007030103A1 (de) * 2007-06-28 2009-01-02 Bode Chemie Gmbh & Co. Kg Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
IT1391668B1 (it) * 2008-07-23 2012-01-17 Universita' Degli Studi Di Trieste Materiali nanocompositi basati su nanoparticelle metalliche stabilizzate con polisaccaridi a struttura ramificata.
WO2010150036A1 (en) * 2009-06-24 2010-12-29 Universidad Autonoma Metropolitana - Xochimilco Sol-gel nanostructured and biocompatible platinum-titania and platinum- silica biocatalysts nanostructured and biocompatible for use in cancer treatment
WO2011045627A1 (en) * 2009-10-12 2011-04-21 Arce Macias, Carlos, Francisco Viricide agents having nanostructured biocatalysts materials of titanium dioxide (tio2) and silicium dioxide (si02) with platinum and iridium modified and dispersed on the surface
WO2011045623A1 (en) * 2009-10-12 2011-04-21 Arce Macias, Carlos Francisco Titanium dioxide nanostructured materials comprising silver and their use as antimicrobials
KR101020041B1 (ko) * 2010-05-10 2011-03-09 박문선 Ｐｔ-Ａｇ-ＣｙＤ（Ａｇ-팽윤성수지） 항균제 및 이의 제조방법
US9125892B2 (en) * 2014-02-03 2015-09-08 George D. Petito Composition for reduced scar formation of wounds

Also Published As

Publication number Publication date
CA3070322A1 (en) 2019-01-24
WO2019016724A2 (en) 2019-01-24
EP3654944A2 (en) 2020-05-27
KR20200091378A (ko) 2020-07-30
JP2020528084A (ja) 2020-09-17
BR112020001041A2 (pt) 2020-07-21
CN111093630A (zh) 2020-05-01
CO2020001810A2 (es) 2020-05-29
EP3654944B1 (en) 2025-11-26
ECSP20013310A (es) 2020-09-30
SG11202000506VA (en) 2020-02-27
US20200147259A1 (en) 2020-05-14
WO2019016724A3 (en) 2019-02-28
EP3654944A4 (en) 2021-08-25
CL2020000129A1 (es) 2020-11-20

Similar Documents

Publication Publication Date Title
CL2008001164A1 (es) Metodos para comunicaciones de emergencia dentro de un sistema de seguridad contra incendios.
CL2009001484A1 (es) Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia.
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
MX372703B (es) Jabon liquido que tiene actividad antibacteriana mejorada.
CL2008003674A1 (es) Composicion farmaceutica como tableta de rapida desintegracion oral que contiene difenhidramina recubiertas con un recubrimiento enmascarador de sabor y granulos de dispersion rapida que comprenden un desintegrador, un alcohol de azucar y/o un sacarido; metodo para preparla, util para afecciones respiratorias, entre otras.
UY33802A (es) Composiciones inmunógenas que comprenden un antígeno relacionado con M72 y que tienen una fuerza iónica baja
BR112013010834B1 (pt) polipeptídeos de fator ix modificados e usos dos mesmos
ECSP11011137A (es) Uso de una composición espumable esencialmente libre de ingredientes con actividad farmacéutica para el tratamiento de la piel humana
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
CL2009000905A1 (es) Composicion comestible que comprende bifidobacterium longum atcc baa-999; y su uso para tratar o prevenir la ansiedad y/o desordenes relacionados con ansiedad.
CL2008003407A1 (es) Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
CL2013001138A1 (es) Composicion que comprende anticuerpo biespecífico cd19xcd3 para tratar masa tumoral de tejido de ganglios linfáticos y/o linfoma extranodal causado por el linfoma b difuso de células grandes (lbdcg); kit farmacéutico; uso de la composición.
CL2007001665A1 (es) Anticuerpo o fragmento del mismo con actividad neutralizante de la proteina nr 10; agente que lo comprende; y su uso para prevenir o tratar una enfermedad inflamatoria.
EA201001628A1 (ru) Модифицированные полипептиды фактора vii и их применение
UY31765A (es) Dihidropirazolonas sustituidas y su uso
CL2007003630A1 (es) Composicion farmaceutica que comprende vitamina c, vitamina e, luteina, zinc, acido graso omega-3 y cobre; metodo de elaboracion; y uso para el tratamiento y/o prevencion de la degeneracion macular relacionada con la edad (amd) y/o retinopatia diabet
AR072654A1 (es) Combinacion biocida para utilizacion en aplicaciones agricolas
JP2014530176A5 (es)
BR112012017554B8 (pt) formulações de anestésicas locais formadoras de sólido para controle da dor
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
MX374840B (es) Analogos de bicalutamida o (s)-bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acumulo lisosomal o glucogenosis.
RU2010140353A (ru) КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ ИНГИБИТОР NFкВ И СТИМУЛЯТОР ОБРАЗОВАНИЯ ТРОПОЭЛАСТИНА
PE20211248A1 (es) Formulacion que comprende material nanoestructurado, biocompatible y biocatalitico para el tratamiento de heridas e infecciones
ES2895910T3 (es) Composiciones multifásicas
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso